Paper39083151
Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.
Cooper SE and 10 others. AIDS Behav, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial. Papers, record 39083151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39083151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacologic Drug Detection and Self-Reported Adherence in the HPTN069/ACTG5305 Phase II PrEP Trial.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Self Report | Major topic |
| HIV Infections | Major topic |
| Anti-HIV Agents | Major topic |
| Tenofovir | Major topic |
| Emtricitabine | Major topic |
| Maraviroc | Major topic |
| Pre-Exposure Prophylaxis | Major topic |
| Drug Monitoring | Major topic |
| Humans | |
| Male | |
| Female | |
| Adult | |
| Double-Blind Method | |
| Middle Aged | |
| Cyclohexanes |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UM1 AI069424 | NIAID NIH HHS | United States | UM1AI069424 | PubMed | NIH RePORTER |
| T32 AI007613 | NIAID NIH HHS | United States | T32AI007613 | PubMed and NIH | NIH RePORTER |
| T32AI007613 | Division of Intramural Research, National Institute of Allergy and Infectious Diseases | T32AI007613 | PubMed and NIH | NIH RePORTER | |
| UM1 AI068619 | NIAID NIH HHS | United States | UM1AI068619 | PubMed and NIH | NIH RePORTER |
| UM1 AI068613 | NIAID NIH HHS | United States | UM1AI068613 | PubMed and NIH | NIH RePORTER |
| UM1 AI069419 | NIAID NIH HHS | United States | UM1AI069419 | PubMed | NIH RePORTER |
| UM1 AI068636 | NIAID NIH HHS | United States | UM1AI068636 | PubMed and NIH | NIH RePORTER |
| UM1 AI068617 | NIAID NIH HHS | United States | UM1AI068617 | PubMed and NIH | NIH RePORTER |
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25296098 | Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. | J Acquir Immune Defic Syndr | 2015 | https://conductscience.org/library/papers/25296098 | PubMed |
| 2 | 26334052 | No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. | Clin Infect Dis | 2015 | https://conductscience.org/library/papers/26334052 | PubMed |
| 3 | 33831911 | Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis. | AIDS | 2021 | https://conductscience.org/library/papers/33831911 | PubMed |
| 4 | 27333000 | Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting. | PLoS One | 2016 | https://conductscience.org/library/papers/27333000 | PubMed |
| 5 | 24926036 | Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24926036 | PubMed |
| 6 | 29090394 | Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value. | AIDS Behav | 2018 | https://conductscience.org/library/papers/29090394 | PubMed |
| 7 | 34143779 | PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. | PLoS Med | 2021 | https://conductscience.org/library/papers/34143779 | PubMed |
| 8 | 26364263 | Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. | Lancet | 2016 | https://conductscience.org/library/papers/26364263 | PubMed |
| 9 | 28902074 | Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California. | J Acquir Immune Defic Syndr | 2017 | https://conductscience.org/library/papers/28902074 | PubMed |
| 10 | 31430318 | Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. | PLoS One | 2019 | https://conductscience.org/library/papers/31430318 | PubMed |
| 11 | 25651245 | Tenofovir-based preexposure prophylaxis for HIV infection among African women. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25651245 | PubMed |
| 12 | 22784040 | Preexposure prophylaxis for HIV infection among African women. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22784040 | PubMed |
| 13 | 21091279 | Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. | N Engl J Med | 2010 | https://conductscience.org/library/papers/21091279 | PubMed |
| 14 | 26414912 | Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066). | AIDS Res Hum Retroviruses | 2016 | https://conductscience.org/library/papers/26414912 | PubMed |
| 15 | 26850270 | Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study. | J Int AIDS Soc | 2016 | https://conductscience.org/library/papers/26850270 | PubMed |
| 16 | 31298662 | Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017. | MMWR Morb Mortal Wkly Rep | 2019 | https://conductscience.org/library/papers/31298662 | PubMed |
| 17 | 35687192 | Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). | AIDS Behav | 2022 | https://conductscience.org/library/papers/35687192 | PubMed |
| 18 | 17577653 | Optimal recall period and response task for self-reported HIV medication adherence. | AIDS Behav | 2008 | https://conductscience.org/library/papers/17577653 | PubMed |
| 19 | 27811319 | Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305). | J Infect Dis | 2017 | https://conductscience.org/library/papers/27811319 | PubMed |
| 20 | 24077970 | Cognitive and field testing of a new set of medication adherence self-report items for HIV care. | AIDS Behav | 2014 | https://conductscience.org/library/papers/24077970 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42802252 | Associations Between Psychosocial Factors and Pre-exposure Prophylaxis (PrEP) Adherence Among Black Men Who Have Sex with Men in Ending the HIV Epidemic Jurisdictions: Findings from Project Adhere. | Arch Sex Behav | 2026 | https://conductscience.org/library/papers/42802252 | PubMed |
| 42484761 | The Effects of Alcohol Intoxication on Sexual Risk Behavior in Men Who Have Sex with Men: Considering PrEP, HIV Viral Load, and Inhibition Conflict. | AIDS Behav | 2026 | https://conductscience.org/library/papers/42484761 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39083151
GET https://conductscience.org/api/papers/v1/39083151/references?page=2